Biscaline

Uses your system voice; voice and rate in settings.

Snapshot

≈ 4 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

Biscaline, also known as 3,5-dimethoxy-4-phenylphenethylamine, is a monoamine receptor modulator of the phenethylamine and desoxyscaline families. It is the analogue of mescaline (3,4,5-dimethoxyphenethylamine) in which the methoxy group at the 4 position has been replaced with a phenyl ring. The drug shows affinity for the serotonin 5-HT 1A receptor (K i = 4,021 nM).

Conversely, it did not bind to the serotonin 5-HT 2A , 5-HT 2B , or 5-HT 2C receptors at the assessed concentrations (K i = >13,400 nM, >10,000 nM, and >14,590 nM, respectively). It is said to have lacked activational effects on the serotonin 5-HT 2A and 5-HT 2B receptors at the assessed concentrations.

Biscaline also bound to the α 2A -adrenergic receptor (K i = 797 nM), but not to the α 1A -adrenergic receptor, the dopamine D 2 receptor, or the monoamine transporters ( , , or ) at the assessed concentrations (K i = >7,510–10,550 nM). It was a very weak monoamine reuptake inhibitor, with values of 457,000 nM for serotonin, 160,000 nM for norepinephrine, and 573,000 nM for dopamine.

Besides the monoamine receptors and transporters, biscaline showed affinity for the rat trace amine-associated receptor 1 (TAAR1) (K i = 586 nM), but not for the mouse TAAR1 (K i = >4,270 nM) and did not activate the human TAAR1 ( = >30,000 nM).…

Biscaline, also known as 3,5-dimethoxy-4-phenylphenethylamine, is a monoamine receptor modulator of the phenethylamine and desoxyscaline families. It is the analogue of mescaline (3,4,5-dimethoxyphenethylamine) in which the methoxy group at the 4 position has been replaced with a phenyl ring. The drug shows affinity for the serotonin 5-HT 1A receptor (K i = 4,021 nM).

Conversely, it did not bind to the serotonin 5-HT 2A , 5-HT 2B , or 5-HT 2C receptors at the assessed concentrations (K i = >13,400 nM, >10,000 nM, and >14,590 nM, respectively). It is said to have lacked activational effects on the serotonin 5-HT 2A and 5-HT 2B receptors at the assessed concentrations.

Biscaline also bound to the α 2A -adrenergic receptor (K i = 797 nM), but not to the α 1A -adrenergic receptor, the dopamine D 2 receptor, or the monoamine transporters ( , , or ) at the assessed concentrations (K i = >7,510–10,550 nM). It was a very weak monoamine reuptake inhibitor, with values of 457,000 nM for serotonin, 160,000 nM for norepinephrine, and 573,000 nM for dopamine.

Besides the monoamine receptors and transporters, biscaline showed affinity for the rat trace amine-associated receptor 1 (TAAR1) (K i = 586 nM), but not for the mouse TAAR1 (K i = >4,270 nM) and did not activate the human TAAR1 ( = >30,000 nM). Biscaline's interaction with the α 2A -adrenergic receptor may be the only significant human pharmacological interaction detected with the compound so far.

Due to its lack of activation of the serotonin 5-HT 2A receptor, biscaline would not be expected to produce psychedelic effects. A variety of 2C analogues and derivatives of biscaline have been synthesized and studied, such as 2C-Ph (2C-BI-1).

Text derived from https://en.wikipedia.org/w/index.php?oldid=1352626895 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

1 named source(s) extracted from the cited revision. A source with no author is shown by its publication; nothing is invented.